Download PDF
Thromb Haemost 2007; 97(01): 161-164
DOI: 10.1160/TH06-03-0160
Letters to the Editor
Schattauer GmbH

Low soluble thrombomodulin activity and antigen is associated with a family history of heart disease while a high level is associated with a personal history of heart disease in type 2 diabetes

Constantine J. Konstantoulas
1   University College London, UK
,
Jackie A. Cooper
1   University College London, UK
,
Ann-Kristin Ohlin
2   Department of Laboratory Medicine, Division of Clinical Chemistry, Lund University, Sweden
,
Stephen E. Humphries
1   University College London, UK
,
Alison H. Goodall
3   University of Leicester, UK
,
Cheng-Hoc Toh
4   Liverpool University, UK
,
Hugh Mather
5   Ealing Hospital, London, UK
,
Helen Ireland
1   University College London, UK
› Author Affiliations
Further Information

Publication History

Received 17 March 2006

Accepted after resubmission 26 November 2006

Publication Date:
28 November 2017 (online)

    Permissions and Reprints

 

 

  • References

  • 1 Esmon CT. Regulation of blood coagulation. Biochim Biophys Acta 2000; 1477: 349-60.
    CrossrefPubMedGoogle Scholar
  • 2 Ishii H, Majerus PW. Thrombomodulin is present in human plasma and urine. J Clin Invest 1985; 76: 2178-81.
    CrossrefPubMedGoogle Scholar
  • 3 Uehara S, Gotoh K, Handa H. Separation and characterization of the molecular species of thrombomodulin in the plasma of diabetic patients. Thromb Res 2001; 104: 325-32.
    CrossrefPubMedGoogle Scholar
  • 4 Inukai T, Fujiwara Y, Tayama K. et al Clinical significance of measurements of urinary and serum thrombomodulins in patients with non-insulin-dependent diabetes mellitus. Diabetes Res Clin Pract 1996; 33: 99-104.
    CrossrefPubMedGoogle Scholar
  • 5 Ohlin AK, Morser J, Ohlin H. Soluble thrombomodulin antigen in plasma is increased in patients with acute myocardial infarction treated with thrombolytic therapy. Thromb Res 1996; 82: 313-22.
    CrossrefPubMedGoogle Scholar
  • 6 Takano S, Kimura S, Ohdama S. et al Plasma thrombomodulin in health and diseases. Blood 1990; 76: 2024-9.
    CrossrefPubMedGoogle Scholar
  • 7 Ishii H, Uchiyama H, Kazama M. Soluble thrombomodulin antigen in conditioned medium is increased by damage of endothelial cells. Thromb Haemost 1991; 65: 618-23.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 8 Blann AD, Seigneur M, Steiner M. et al Circulating endothelial cell markers in peripheral vascular disease: relationship to the location and extent of atherosclerotic disease. Eur J Clin Invest 1997; 27: 916-21.
    CrossrefPubMedGoogle Scholar
  • 9 Carr ME. Diabetes mellitus: a hypercoagulable state. J Diabetes Complications 2001; 15: 44-54.
    CrossrefPubMedGoogle Scholar
  • 10 Li YH, Chen JH, Wu HL. et al G-33A mutation in the promoter region of thrombomodulin gene and its association with coronary artery disease and plasma soluble thrombomodulin levels. Am J Cardiol 2000; 85: 8-12.
    CrossrefPubMedGoogle Scholar
  • 11 Kunz G, Ireland HA, Stubbs PJ. et al Identification and characterization of a thrombomodulin gene mutation coding for an elongated protein with reduced expression in a kindred with myocardial infarction. Blood 2000; 95: 569-76.
    CrossrefPubMedGoogle Scholar
  • 12 Salomaa V, Matei C, Aleksic N. et al Soluble thrombomodulin as a predictor of incident coronary heart disease and symptomless carotid artery atherosclerosis in the Atherosclerosis Risk in Communities (ARIC) Study: a case-cohort study. Lancet 1999; 353: 1729-34.
    CrossrefPubMedGoogle Scholar
  • 13 Ireland H, Konstantoulas CJ, Cooper JA. et al EPCR Ser219Gly: elevated sEPCR, prothrombin F1+2, risk for coronary heart disease, and increased sEPCR shedding in vitro. Atherosclerosis 2005; 183: 283-92.
    CrossrefPubMedGoogle Scholar
  • 14 Ohlin AK, Larsson K, Hansson M. Soluble thrombomodulin activity and soluble thrombomodulin antigen in plasma. J Thromb Haemost 2005; 3: 976-82.
    CrossrefPubMedGoogle Scholar
  • 15 Bland JM, Altman DG. Multiple significance tests: the Bonferroni method. Br Med J 1995; 310: 170
    CrossrefPubMedGoogle Scholar
  • 16 Oida K, Takai H, Maeda H. et al Plasma thrombomodulin concentration in diabetes mellitus. Diabetes Res Clin Pract 1990; 10: 193-6.
    CrossrefPubMedGoogle Scholar
  • 17 Hergesell O, Andrassy K, Geberth S. et al Plasma thrombomodulin levels are dependent on renal function. Thromb Res 1993; 72: 455-8.
    CrossrefPubMedGoogle Scholar
  • 18 Weiner DE, Tighiouart H, Stark PC. et al Kidney disease as a risk factor for recurrent cardiovascular disease and mortality. Am J Kidney Dis 2004; 44: 198-206.
    CrossrefPubMedGoogle Scholar
  • 19 Mann JF, Gerstein HC, Pogue J. et al Cardiovascular risk in patients with early renal insufficiency: implications for the use of ACE inhibitors. Am J Cardiovasc Drugs 2002; 2: 157-62.
    CrossrefPubMedGoogle Scholar
  • 20 Luria MH, Knoke JD, Margolis RM. et al Acute myocardial infarction: prognosis after recovery. Ann Intern Med 1976; 85: 561-5.
    CrossrefPubMedGoogle Scholar
  • 21 Normand ST, Glickman ME, Sharma RG. et al Using admission characteristics to predict short-term mortality from myocardial infarction in elderly patients. Results from the Cooperative Cardiovascular Project. J Am Med Assoc 1996; 275: 1322-8.
    CrossrefPubMedGoogle Scholar
  • 22 Kirtane AJ, Leder DM, Waikar SS. et al Serum blood urea nitrogen as an independent marker of subsequent mortality among patients with acute coronary syndromes and normal to mildly reduced glomerular filtration rates. J Am Coll Cardiol 2005; 45: 1781-6.
    CrossrefPubMedGoogle Scholar